TET2 and lymphoid neoplasm: Cyril Quivoron et al. investigated Tet2 deficiency in mice and found that TET2 mutations present in lymphoid tumour cells may occur at both the early and later steps of lymphoid development and that the impairment of TET2 function or/and expression predisposes to the development of lymphomagenesis [13].